Michael S. Okun

Active 2001–2025

269
Papers
40,254
Citations
100
h-index
257
i10-index

Citations

Citations per year for Michael S. Okun1982: 1 citations1985: 3 citations1986: 3 citations1987: 5 citations1988: 6 citations1989: 2 citations1990: 2 citations1991: 3 citations1992: 1 citations1993: 1 citations1994: 2 citations1995: 2 citations1996: 2 citations1997: 1 citations1998: 2 citations1999: 2 citations2000: 3 citations2001: 5 citations2002: 6 citations2003: 21 citations2004: 33 citations2005: 53 citations2006: 67 citations2007: 103 citations2008: 128 citations2009: 132 citations2010: 214 citations2011: 225 citations2012: 261 citations2013: 252 citations2014: 299 citations2015: 286 citations2016: 264 citations2017: 361 citations2018: 295 citations2019: 1,013 citations2020: 1,401 citations2021: 1,589 citations2022: 1,622 citations2023: 1,417 citations2024: 2,297 citations2025: 1,196 citations2026: 72 citations1983–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,096 citing papers, 23.7% of this breakdownChina: 1,757 citing papers, 10.2% of this breakdownUnited Kingdom: 1,320 citing papers, 7.7% of this breakdownGermany: 1,088 citing papers, 6.3% of this breakdownCanada: 818 citing papers, 4.7% of this breakdownItaly: 776 citing papers, 4.5% of this breakdownFrance: 592 citing papers, 3.4% of this breakdownNetherlands: 533 citing papers, 3.1% of this breakdownAustralia: 505 citing papers, 2.9% of this breakdownSpain: 477 citing papers, 2.8% of this breakdownIndia: 344 citing papers, 2% of this breakdownJapan: 318 citing papers, 1.8% of this breakdown
0%23.7%Other 26.9%

Fields

  • Medicine61%
  • Neuroscience14.8%
  • Biochemistry, Genetics and Molecular Biology10%
  • Psychology4.3%
  • Health Professions4.3%
  • Engineering1.6%
  • Other4%

Topics

  • Parkinson's Disease Mechanisms and Treatments15.2%
  • Neurological disorders and treatments11.9%
  • Transcranial Magnetic Stimulation Studies2.9%
  • Neuroscience and Neural Engineering2.8%
  • Genetic Neurodegenerative Diseases2.4%
  • Alzheimer's disease research and treatments1.7%
  • Other63.1%

Coauthors

All papers

Open in search
  1. Parkinson's disease

    Authors: , , - The Lancet 2021 cited by 3,623

  2. Diagnosis and Treatment of Parkinson Disease

    Authors: , - JAMA 2020 cited by 2,826

  3. The Emerging Evidence of the Parkinson Pandemic

    Authors: , , , - Journal of Parkinson s Disease 2018 cited by 1,963

  4. Genome-wide association study reveals genetic risk underlying Parkinson's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katrina Gwinn, Marcel van der Brug, Grisel Lopez, Stephen J. Chanock, Arthur Schatzkin, Yikyung Park, Albert R. Hollenbeck, Jianjun Gao, Xuemei Huang, Nick W Wood, Delia Lorenz, Günther Deuschl, Honglei Chen, Olaf Rieß, John Hardy, Andrew Singleton, Thomas Gasser - Nature Genetics 2009 cited by 1,954

  5. Interrogating the Genetic Determinants of Tourette’s Syndrome and Other Tic Disorders Through Genome-Wide Association Studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christel Depienne, Yulia Worbe, Andreas Hartmann, Cathy L. Budman, Renata Rizzo, Gholson J. Lyon, William M. McMahon, James R. Batterson, Daniëlle C. Cath, Irene A. Malaty, Michael S. Okun, Cheston M. Berlin, Douglas W. Woods, Paul C. Lee, Joseph Jankovic, Mary M. Robertson, Donald L. Gilbert, Lawrence W. Brown, Barbara Coffey, Andrea Dietrich, Pieter J. Hoekstra, Samuel Kuperman, Samuel H. Zinner, Pétur Lúðvígsson, Evald Sæmundsen, Ólafur Thorarensen, Gil Atzmon, Nir Barzilai, Michael Wagner, Rainald Moessner, Roel A. Ophoff, Carlos N. Pato, Michele T. Pato, James A. Knowles, Joshua L. Roffman, Jordan W. Smoller, Randy L. Buckner, A. Jeremy Willsey, Jay A. Tischfield, Gary A. Heiman, Hreinn Stefánsson, Kāri Stefánsson, Daniëlle Posthuma, Nancy J. Cox, David L. Pauls, Nelson B. Freimer, Benjamin M. Neale, Lea K. Davis, Peristera Paschou, Giovanni Coppola, Carol A. Mathews, Jeremiah M. Scharf - American Journal of Psychiatry 2019 cited by 443

  6. Deep Brain Stimulation for Parkinson Disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Archives of Neurology 2010 cited by 965

  7. Emerging therapies in Parkinson disease — repurposed drugs and new approaches

    Authors: , , , - Nature Reviews Neurology 2019 cited by 296

  8. Deep-Brain Stimulation for Parkinson's Disease

    Authors: - New England Journal of Medicine 2012 cited by 530

  9. Six Action Steps to Address Global Disparities in Parkinson Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pramod Kumar Pal, Hiral Shah, Ali Shalash, Todd Sherer, Bernadette Siddiqui, Ted Thompson, Andreas Ullrich, Richard Walker, Tarun Dua - JAMA Neurology 2022 cited by 140

  10. A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Movement Disorders 2023 cited by 82

  11. Optimal deep brain stimulation sites and networks for stimulation of the fornix in Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrés M. Lozano, Andreas Horn - Nature Communications 2022 cited by 100

  12. A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Angel Figueroa, Ani Arkun, Matthew Brodsky, William G. Ondo, Christine Hunter, Joohi Jimenez‐Shahed, Alicia Palao, Janis M. Miyasaki, Julie So, James W. Tetrud, Liza Reys, Katharine Smith, Carlos Singer, Anita Blenke, David Russell, Candace Cotto, Joseph H. Friedman, Margaret C. Lannon, Lin Zhang, Edward Drasby, Rajeev Kumar, Thyagarajan Subramanian, Donna Stuppy Ford, David A. Grimes, Diane Côté, Jennifer Conway, Andrew Siderowf, Marian L. Evatt, Barbara Sommerfeld, Abraham Lieberman, Michael S. Okun, Ramon L. Rodriguez, Stacy Merritt, Camille Swartz, W. R. Wayne Martin, Pamela King, Natividad Stover, Stephanie Guthrie, Ray L. Watts, Anwar Ahmed, Hubert H. Fernandez, Adrienna Winters, Zoltán Mari, Ted M. Dawson, Becky Dunlop, Andrew Feigin, Barbara Shannon, Melissa J. Nirenberg, Mattson Ogg, Samuel A. Ellias, Cathi-Ann Thomas, Karen Frei, Iván Bódis-Wollner, Sofya Glazman, Thomas A. Mayer, Robert A. Hauser, Rajesh Pahwa, April Langhammer, Ranjit Ranawaya, Lorelei Derwent, Kapil D. Sethi, Buff Farrow, Rajan Prakash, Irene Litvan, Annette Robinson, Alok Sahay, Maureen Gartner, Vanessa K. Hinson, Samuel Markind, Melisa Pelikan and 62 more - JAMA Neurology 2014 cited by 395

  13. Tourette syndrome: clinical features, pathophysiology, and treatment

    Authors: , , , , , - The Lancet Neurology 2022 cited by 182

  14. Deep brain stimulation for refractory major depressive disorder: a comprehensive review

    Authors: , , , , - Molecular Psychiatry 2024 cited by 71

  15. Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care

    Authors: , , , , , , , , - The Lancet Neurology 2020 cited by 236

  16. Past, Present, and Future of Deep Brain Stimulation: Hardware, Software, Imaging, Physiology and Novel Approaches

    Authors: , , , , , , , - Frontiers in Neurology 2022 cited by 113

  17. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cathrin M. Buetefisch, Robert E. Gross, Corneliu Luca, Jonathan Jagid, Gonzalo J. Revuelta, István Takács, Michael Pourfar, Alon Y. Mogilner, Andrew P. Duker, George Mandybur, Joshua M. Rosenow, Scott E. Cooper, Michael C. Park, Suketu M. Khandhar, Mark Sedrak, Fenna T. Phibbs, Julie G. Pilitsis, Ryan J. Uitti, Philip A. Starr - The Lancet Neurology 2020 cited by 151

  18. Chronic embedded cortico-thalamic closed-loop deep brain stimulation for the treatment of essential tremor

    Authors: , , , , , , , , , - Science Translational Medicine 2020 cited by 157

  19. Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David E. Vaillancourt - The Lancet Digital Health 2019 cited by 117

  20. Neurite orientation dispersion and density imaging (NODDI) and free‐water imaging in Parkinsonism

    Authors: , , , , , , , , , , , , , , , , , - Human Brain Mapping 2019 cited by 116

  21. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2012 cited by 407

  22. Progression marker of Parkinson’s disease: a 4-year multi-site imaging study

    Authors: , , , , , , , - Brain 2017 cited by 197

  23. Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders

    Authors: , , , , , , , , , , , , - Neurology 2019 cited by 499

  24. Evidence-based guideline update: Treatment of essential tremor

    Authors: , , , , , , , , - Neurology 2011 cited by 343